Daniel Wrapp, an assistant professor in medicine at Duke University, shared how he helped find the first human antibodies ...
In April, the FDA announced an ambitious plan to phase out animal testing requirements for monoclonal antibodies and other therapies in an effort to improve drug safety and reduce R&D costs. The goal ...
New research from The Wistar Institute's Montaner lab—led by Wistar Executive Vice President, director of the HIV Cure and Viral Disease Center, and Herbert Kean, M.D., Family Professor, Luis Montaner ...
BEIJING & PRAGUE--(BUSINESS WIRE)--Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human ...
Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
The global resurgence of mpox, along with its evolving epidemiology and sustained human-to-human transmission, highlights the need to investigate the human antibody response to key monkeypox virus ...
Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results